Holen Sie sich die Stockscreener-App
24.28
0.96%
0.23
Handel nachbörslich:
24.16
-0.12
-0.49%
Schlusskurs vom Vortag:
$24.05
Offen:
$23.81
24-Stunden-Volumen:
9.14M
Relative Volume:
0.96
Marktkapitalisierung:
$9.45B
Einnahmen:
$3.14B
Nettoeinkommen (Verlust:
$-3.36B
KGV:
-2.7812
EPS:
-8.73
Netto-Cashflow:
$-4.03B
1W Leistung:
-0.78%
1M Leistung:
-12.16%
6M Leistung:
-20.05%
1J Leistung:
-66.51%
1-Tages-Spanne:
$23.33
$24.34
1-Wochen-Bereich:
$23.33
$24.66
52-Wochen-Spanne:
$23.15
$79.96
Moderna Inc Stock (MRNA) Company Profile
Firmenname
Moderna Inc
Sektor
Branche
Telefon
(617) 714-6500
Adresse
325 BINNEY STREET, CAMBRIDGE
Vergleichen Sie MRNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
24.28 | 9.41B | 3.14B | -3.36B | -4.03B | -8.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Eingeleitet | Citigroup | Neutral |
| 2025-02-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-01-29 | Herabstufung | Goldman | Buy → Neutral |
| 2024-12-18 | Herabstufung | Argus | Buy → Hold |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-19 | Eingeleitet | Berenberg | Hold |
| 2024-11-18 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Underperform |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-09-13 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-09-13 | Herabstufung | Jefferies | Buy → Hold |
| 2024-09-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-08-28 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2024-08-07 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2024-08-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2024-01-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-11-29 | Eingeleitet | Canaccord Genuity | Hold |
| 2023-11-03 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-11-02 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2023-08-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-07-24 | Eingeleitet | William Blair | Mkt Perform |
| 2023-07-14 | Eingeleitet | HSBC Securities | Reduce |
| 2023-06-26 | Hochstufung | UBS | Neutral → Buy |
| 2023-04-26 | Eingeleitet | Guggenheim | Neutral |
| 2023-03-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-24 | Herabstufung | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | Hochstufung | Jefferies | Hold → Buy |
| 2022-12-14 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | Hochstufung | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-02-01 | Hochstufung | Redburn | Sell → Neutral |
| 2022-01-26 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2022-01-21 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-21 | Eingeleitet | UBS | Neutral |
| 2021-12-07 | Eingeleitet | Cowen | Market Perform |
| 2021-11-09 | Eingeleitet | Wolfe Research | Outperform |
| 2021-10-22 | Eingeleitet | Deutsche Bank | Sell |
| 2021-10-15 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-08-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | Bestätigt | Jefferies | Hold |
| 2021-02-01 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | Herabstufung | Needham | Buy → Hold |
| 2020-11-23 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-11-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | Herabstufung | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-07-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Eingeleitet | Jefferies | Buy |
| 2020-06-30 | Eingeleitet | Argus | Buy |
| 2020-06-08 | Eingeleitet | Barclays | Overweight |
| 2020-04-30 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-10-25 | Eingeleitet | ROTH Capital | Buy |
| 2019-04-05 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Moderna Inc Aktie (MRNA) Neueste Nachrichten
Florida plans to end all state vaccine mandates, including for schools - MarketScreener
Pfizer, Moderna, Novavax respond to Trump’s criticism of COVID shot success - Seeking Alpha
Pfizer, Moderna defend COVID vaccine effectiveness after Trump remarks - Reuters
Florida to eliminate all state vaccine mandates, surgeon general says - Seeking Alpha
Moderna's mRNA Technology Remains Valuable but Covid Vaccine Headwinds Create Pressure - Morningstar
Moderna : Recognizes the Success of Operation Warp Speed and its Ongoing Commitment to Transparency - MarketScreener
West Coast states launch health alliance amid changes at CDC - Seeking Alpha
Moderna (MRNA) Receives a Hold from Argus Research - The Globe and Mail
Stock Analysis | Moderna OutlookA Cautious Investment With Mixed Signals - AInvest
Measuring Moderna Inc.’s beta against major indicesJuly 2025 Action & Weekly Breakout Watchlists - Newser
PDT Partners LLC Has $6.21 Million Holdings in Moderna, Inc. $MRNA - MarketBeat
SHANDA ASSET MANAGEMENT HOLDINGS Ltd Makes New Investment in Moderna, Inc. $MRNA - MarketBeat
Volume spikes in Moderna Inc. stock – what they meanPortfolio Gains Report & Community Driven Trade Alerts - Newser
Quotient Sciences and CPI to expedite RNA therapy development - Pharmaceutical Technology
Moderna Inc. (NASDAQ: MRNA) Shares Rally 0.42% as Oncology Advances and Rare Disease Trials Fuel Optimism - AInvest
Moderna Inc. stock daily chart insightsLong Setup & Weekly Top Gainers Alerts - Newser
Has Moderna Inc. formed a bullish divergence2025 Investor Takeaways & AI Enhanced Trading Signals - Newser
FDA quietly positions itself to disrupt childhood vaccine schedule - BioCentury
Can Moderna Inc. disrupt its industry2025 Analyst Calls & Community Consensus Trade Alerts - khodrobank.com
Price action breakdown for Moderna Inc.2025 Bull vs Bear & AI Powered Buy and Sell Recommendations - Newser
South Korea clears Moderna’s Spikevax LP.8.1 vaccine for COVID-19 - BioWorld MedTech
How hedge fund analytics apply to Moderna Inc. stockEntry Point & Fast Moving Market Watchlists - Newser
Moderna Inc. stock outlook for YEARWatch List & Daily Chart Pattern Signals - Newser
Should you avoid Moderna Inc. stock right nowJuly 2025 Trends & Weekly Top Performers Watchlists - khodrobank.com
Risk adjusted return profile for Moderna Inc. analyzedWeekly Investment Summary & AI Powered Trade Plan Recommendations - Newser
Pfizer, Moderna, and the Political-Economic Fallout from Trump's Data Demands on COVID Vaccines - AInvest
Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism - The Lawton Constitution
Pfizer, Moderna in focus as Trump demands answers on COVID success - Seeking Alpha
First-Ever Data: Moderna's Revolutionary mRNA Treatments for Three Rare Metabolic Diseases at ICIEM 2025 - Stock Titan
Is Moderna Stock Underperforming the S&P 500? - MSN
Is Moderna Stock Underperforming The S&P 500? - Barchart.com
What is the earnings history of Moderna Inc.2025 Risk Factors & Fast Entry Momentum Trade Alerts - khodrobank.com
Trump Demands Pfizer, Other Covid Drug Makers To 'Justify The Success,' Show Their Results Amid New FDA Restrictions—'Clear Up This Mess'Moderna (NASDAQ:MRNA), Pfizer (NYSE:PFE) - Benzinga
FORA Capital LLC Boosts Holdings in Moderna, Inc. $MRNA - MarketBeat
Moderna (MRNA) Gains FDA Nod for Next-Gen COVID-19 Vaccine Targeting LP.8.1 Variant - Yahoo Finance
Is Moderna Inc. stock a value trapJuly 2025 Volume & Low Volatility Stock Recommendations - khodrobank.com
Dow Update: Is Moderna Inc. stock a value trapJuly 2025 Movers & Low Risk High Win Rate Stock Picks - khodrobank.com
Moderna Announces Positive Phase 3 Results for Seasonal Influenza Vaccine - Oak Ridger
What’s the outlook for Moderna Inc.’s sectorJuly 2025 Intraday Action & Stepwise Trade Execution Plans - خودرو بانک
Detecting support and resistance levels for Moderna Inc.July 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser
Can Traders Expect Breakout From Moderna Inc. This Week getLinesFromResByArray error: size == 0 - thegnnews.com
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In WorksModerna (NASDAQ:MRNA), BioNTech (NASDAQ:BNTX) - Benzinga
Aristides Capital LLC Acquires Shares of 20,000 Moderna, Inc. $MRNA - MarketBeat
Earnings visualization tools for Moderna Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
What moving averages say about Moderna Inc.Trade Volume Report & Weekly High Potential Stock Alerts - Newser
Moderna (NASDAQ:MRNA) Trading Down 5.2% After Analyst Downgrade - MarketBeat
Moderna, Inc. $MRNA Shares Sold by Groupe la Francaise - MarketBeat
Finanzdaten der Moderna Inc-Aktie (MRNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):